What is it about?
We discussed the current treatment options with chemotherapy or targeted therapy in patients with metastatic soft tissue sarcomas. We specifically discussed trabectedin as chemotherapeutic agent for soft tissue sarcomas
Featured Image
Why is it important?
This publication gives a timely overview of the currently available systemic treatment options in patients with soft tissue sarcomas, in particular the role of trabectedin.
Read the Original
This page is a summary of: Advanced soft-tissue sarcoma and treatment options: critical appraisal of trabectedin, Cancer Management and Research, August 2016, Dove Medical Press,
DOI: 10.2147/cmar.s86746.
You can read the full text:
Contributors
The following have contributed to this page
